These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1664073)

  • 1. Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue.
    Barnes NM; Costall B; Egli P; Horovitz ZP; Ironside JW; Naylor RJ; Williams TJ
    Neuropharmacology; 1991 Aug; 30(8):907-14. PubMed ID: 1664073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ACE inhibitor [3H]SQ29,852 identifies a high affinity recognition site located in the human temporal cortex.
    Barnes NM; Costall B; Egli P; Horovitz ZP; Ironside JW; Naylor RJ; Williams TJ
    Brain Res Bull; 1990 Jul; 25(1):183-5. PubMed ID: 2207707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease.
    Barnes NM; Cheng CH; Costall B; Naylor RJ; Williams TJ; Wischik CM
    Eur J Pharmacol; 1991 Aug; 200(2-3):289-92. PubMed ID: 1664329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
    DeForrest JM; Waldron TL; Harvey C; Scalese R; Hammerstone S; Powell JR; Karanewsky D
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):121-7. PubMed ID: 1696654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of angiotensin converting enzyme by [3H]captopril binding.
    Strittmatter SM; Snyder SH
    Mol Pharmacol; 1986 Feb; 29(2):142-8. PubMed ID: 3005826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reduction in alcohol intake produced by enalapril is not attenuated by centrally administered angiotensin inhibitors.
    Robertson JM; Harding S; Grupp LA
    Alcohol; 1994; 11(4):295-9. PubMed ID: 7945983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]Captopril binding to membrane associated angiotensin converting enzyme.
    Strittmatter SM; Kapiloff MS; Snyder SH
    Biochem Biophys Res Commun; 1983 May; 112(3):1027-33. PubMed ID: 6303332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
    Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of endothelial-bound angiotensin converting enzyme, in vivo.
    Catravas JD; Ryan JW; Chung AY; Quinn NE; Anthony BL
    Br J Pharmacol; 1990 Sep; 101(1):121-7. PubMed ID: 2282454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
    DeForrest JM; Waldron TL; Harvey C; Scalese B; Rubin B; Powell JR; Petrillo EW; Cushman DW
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):730-6. PubMed ID: 2481187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency.
    Sica DA; Cutler RE; Parmer RJ; Ford NF
    Clin Pharmacokinet; 1991 May; 20(5):420-7. PubMed ID: 1652404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoradiographic visualization of angiotensin-converting enzyme in rat brain with [3H]captopril: localization to a striatonigral pathway.
    Strittmatter SM; Lo MM; Javitch JA; Snyder SH
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1599-603. PubMed ID: 6324207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors: accomplishments and challenges.
    Petrillo EW; Powell JR; Cushman DW; Ondetti MA
    Clin Exp Hypertens A; 1987; 9(2-3):235-41. PubMed ID: 3038385
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
    Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
    J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative cytotoxicity of angiotensin-converting enzyme inhibitors in cultured rat hepatocytes.
    Jurima-Romet M; Huang HS
    Biochem Pharmacol; 1993 Dec; 46(12):2163-70. PubMed ID: 8274149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG; Rao NM
    Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells.
    Thwaites DT; Cavet M; Hirst BH; Simmons NL
    Br J Pharmacol; 1995 Mar; 114(5):981-6. PubMed ID: 7780654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
    Sarro GD; Paola ED; Gratteri S; Gareri P; Rispoli V; Siniscalchi A; Tripepi G; Gallelli L; Citraro R; Russo E
    Pharmacol Res; 2012 Mar; 65(3):285-96. PubMed ID: 22107891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.
    Barnes JM; Barnes NM; Champaneria S; Costall B; Naylor RJ
    Neuropharmacology; 1990 Nov; 29(11):1037-45. PubMed ID: 2087255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.